|
Market Closed -
NYSE
04:00:03 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 251.82 USD | -0.43% |
|
+4.11% | +45.12% |
| Oct. 28 | Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235 | MT |
| Oct. 27 | Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $279 From $251 | MT |
| Market Cap | 27.71B 24.83B 22.85B 20.69B 38.71B 2,631B 39.41B 272B 109B 1,383B 104B 102B 4,364B | P/E 2026 * |
24.4x | P/E 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise Value | 32.69B 29.3B 26.97B 24.41B 45.68B 3,104B 46.5B 321B 129B 1,632B 123B 120B 5,150B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.54x |
| Free-Float |
67.61% | Yield 2026 * |
1.31% | Yield 2027 * | 1.31% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DGX | Delayed | |
CBOE
| DGX | Real-time | |
|
London S.E.
| 0KSX | Delayed | |
|
Boerse Muenchen
| QDI | Real-time | |
|
Tradegate
| QDI | Real-time | |
|
Berne S.E.
| QDI | End-of-day quote | |
|
Mexican S.E.
| DGX * | End-of-day quote | |
|
Deutsche Boerse AG
| QDI | Delayed | |
|
Börse Stuttgart
| QDI | Delayed | |
|
Xetra
| QDI | Delayed | |
|
Borsa Italiana
| 1QDX | End-of-day quote |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | -0.43% | ||
| 1 week | +4.11% | ||
| Current month | +8.04% | ||
| 1 month | +8.04% | ||
| 3 months | +7.48% | ||
| 6 months | +29.67% | ||
| Current year | +45.12% |
| 1 week | 239.59 |  | 256.99 |
| 1 month | 223.5 | | 256.99 |
| Current year | 171.18 | | 256.99 |
| 1 year | 171.18 | | 256.99 |
| 3 years | 123.04 | | 256.99 |
| 5 years | 119.59 | | 256.99 |
| 10 years | 73.02 | | 256.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 2022-02-02 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 2022-07-10 |
Murali Balakumar
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 2004-11-30 |
Timothy Ring
BRD | Director/Board Member | 68 | 2011-12-06 |
James Davis
CHM | Chairman | 63 | 2023-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Free | Director | 135 | 0.0001% | ||
| 9/1/26 | Sell | Chief Executive Officer | -10,000 | 0.0091% | ||
| 8/28/26 | Exercice | General Counsel | 69,031 | 0.0625% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +4.11% | +43.28% | +94.59% | 27.71B | |
| -0.09% | -3.44% | +17.68% | +32.70% | 115B | |
| -1.02% | +0.89% | +1.37% | +111.87% | 98.85B | |
| -4.98% | +2.56% | +114.42% | +1,003.33% | 59.72B | |
| -1.84% | +9.86% | +43.22% | +82.37% | 29.34B | |
| +1.44% | +1.95% | -6.67% | +93.57% | 30.06B | |
| +0.99% | +1.79% | +30.98% | +413.15% | 22B | |
| -0.72% | +5.53% | -18.63% | -12.38% | 20.66B | |
| -.--% | -0.63% | -4.27% | +31.71% | 17.09B | |
| -2.07% | -27.56% | -25.98% | +45.52% | 12.72B | |
| Average | -0.87% | -0.49% | +19.54% | +189.64% | 43.36B | |
| Weighted average by Cap. | -1.04% | +0.23% | +25.76% | +213.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.08B 10.83B 9.97B 9.02B 16.89B 1,147B 17.19B 119B 47.65B 603B 45.35B 44.38B 1,903B | 12.62B 11.31B 10.41B 9.43B 17.64B 1,198B 17.95B 124B 49.77B 630B 47.36B 46.35B 1,988B |
| Net income | 1.16B 1.04B 960M 869M 1.63B 111B 1.66B 11.42B 4.59B 58.11B 4.37B 4.27B 183B | 1.24B 1.11B 1.02B 924M 1.73B 117B 1.76B 12.14B 4.88B 61.76B 4.64B 4.54B 195B |
| Net Debt | 4.99B 4.47B 4.11B 3.72B 6.97B 474B 7.09B 48.94B 19.67B 249B 18.72B 18.32B 786B | 4.34B 3.89B 3.58B 3.24B 6.06B 412B 6.17B 42.56B 17.1B 217B 16.27B 15.93B 683B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $251.82 | -0.43% | 919,589 |
| 26-10-29 | $252.92 | +2.97% | 946,275 |
| 26-10-28 | $245.62 | +1.26% | 932,796 |
| 26-10-27 | $242.56 | -0.16% | 919,017 |
| 26-10-26 | $242.95 | +0.44% | 959,622 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
